Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.

It is possibly an even more powerful weight loss therapy than GLP-1 medications, especially for people who still have a lot of weight to lose. Rao says, “This will be very individualized.

A WOMAN who went on Mounjaro to lose weight has been forced to quit after suffering horrendous hair loss. Carrie initially took to TikTok to bemoan how much her hair has thinned out since starting ...

Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. Jama, 325(14), 1414-1425 ...

When I first gained weight, it didn’t bother me at first. Yes, none of my clothes fitted me my 5ft 4ins frame any more, but I was simply grateful to be alive for my daughter Mabel, now seven.

Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June ...

Protagonist Therapeutics' partners ought to secure two approvals for blockbuster drugs within the next year. Click here to ...

W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...